Kazakhstan

Central Asia

Contents

1. Regulatory Overview
2. Regulatory Pathways

Regulatory Overview

Kazakhstan is regulated by the DQMDM (Department for Quality of Medicinal Drugs and Medical Devices). The country has 1 documented regulatory pathway for accessing unapproved or unlicensed medicines, covering named patient programs, compassionate use schemes, and special access arrangements.

Regulatory Authority

DQMDM (Department for Quality of Medicinal Drugs and Medical Devices)

Regulatory Pathways (1)

DQMDM Special Import Authorization – Kazakhstan 30 days

Kazakhstan Department for Quality of Medicinal Drugs and Medical Devices special import authorization for unregistered medicines for patients with serious conditions.

Application Form: DQMDM Special Import Form

Legal Basis: Kazakhstan Law on Medications

Eligibility: Serious or life-threatening condition with no locally registered alternative

Reference: Kazakhstan Drug Access Guidelines

Kazakhstan

ISO Code	`KZ`
Region	Central Asia
Regulatory Authority	DQMDM (Department for Quality of Medicinal Drugs and Medical Devices)
Pathways	1 documented
Drugs Available	0 documented